ArticleAnnals of medicine and surgery (2012)2022

FDA approves Ruxolitinib (Opzelura) for Vitiligo Therapy: A breakthrough in the field of dermatology.

Ayesha Sheikh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.